Status:
ACTIVE_NOT_RECRUITING
Nicotine Replacement Therapy Prescribing and Lung Cancer Screening in Hospitalized Patients
Lead Sponsor:
Medical University of South Carolina
Collaborating Sponsors:
South Carolina Clinical & Translational Research Institute (SCTR)
Conditions:
Tobacco Use Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Investigators are evaluating an EHR-based, non-interruptive alert to increase NRT prescribing in the hospital and at discharge for hospitalized patients. Investigators will investigate two randomized ...
Detailed Description
Efforts to decrease cancer-related morbidity and mortality include increasing smoking cessation, however smoking remains prevalent. Classically, alerts within the electronic health record (EHR) are im...
Eligibility Criteria
Inclusion
- Patients
- Hospitalized patients admitted to a General Medicine Service at MUSC Charleston
- Identified as actively smoking tobacco via nursing admission screening
- Admitted by a resident physician participating in the study (as indicated by the H\&P note)
Exclusion
- • None
- Resident Physicians:
- Inclusion Criteria:
- • Internal medicine resident physicians rotating on the hospitalist service at MUSC Health Charleston
Key Trial Info
Start Date :
November 17 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2026
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT07164404
Start Date
November 17 2025
End Date
April 1 2026
Last Update
December 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of South Carolina
Charleston, South Carolina, United States, 29407